Clinical Trials List
2007-11-01 - 2011-12-31
Phase II
Terminated5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- PEI-JER CHEN Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 林盈君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王緯書 Division of Hematology & Oncology
- 余垣斌 Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
- 陳博明 Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳彥仰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
34 participants
-
Global
49 participants
